Alzheimer ‘s disease psychosis – Talk Bio

Actionable Insights Powered by AI

Big Pharma-Backed MapLight Plots IPO to Advance Neuro Pipeline

3 weeks ago talkbio0Tagged Alzheimer 's disease psychosis, Biological Factors, Clinical Trials, IPO, MapLight Therapeutics, Morgan Stanley, Muscarinic Agonists, neuro pipeline, Schizophrenia, Series D financing

MapLight Therapeutics; IPO; neuro pipeline; Alzheimer’s disease psychosis; schizophrenia; M1/M4 muscarinic agonist; Series D financing; Morgan Stanley; biopharmaceutical; clinical trials